Fibromyalgia and Chronic Fatigue Syndrome (ME/CFS) Research Center Makes Good
Jarred Younger was lured away from Stanford by a University that wanted to get a lead in an emerging field. By definition emerging fields are not quite there yet…they’re emerging. Picking a winner in the medical field sweepstakes may be a bit like backing...
Ampligen Co-Inventor / Head of Hemispherx Biopharma Fired: Implications for ME/CFS Drug Unclear
Bill Carter – the long-time CEO of Hemispherx Biopharma, the producer of Ampligen, was fired as the company announced new austerity measures. ME/CFS practitioners laud Ampligen but it’s never in 30 years made it to market. It’s been called “A...
Low Dose Naltrexone Drug Combination Proposed for Chronic Fatigue Syndrome (ME/CFS)
In 2011 the CFIDS Association (now the Solve ME/CFS Initiative) engaged a “drug repositioning” company called Biovista to search through thousands of drugs to find a new approach to ME/CFS. Biovista’s algorithm identified “every known gene,...
Fibromyalgia – Neuroinflammatory Disease? Savella – Anti- Inflammatory Drug?
Sometimes you just guess right. Natelson and Shungu and company made two big guesses in this oh so interesting clinical trial. First, they guessed that people with fibromyalgia would have the same increased brain lactate levels that they’ve found that people...
Fibromyalgia – The Savella Story
Milnacipran (brand names: Savella, Ixel) is the third and last drug the FDA approved for the treatment of fibromyalgia in the United States. The fourth serotonin–norepinephrine reuptake inhibitor (SNRI), to be introduced in the U.S., Savella stops the reuptake of...Lives Interrupted Latest Story
Allyn Archer
Atlanta, United States
Former occupation: Architect, Professor of Architecture
$2,768,291
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
